Pluristem Therapeutics's (PSTI) shares are halted after it says that the FDA has suspended the...

|About: Pluristem Therapeutics, Inc. (PSTI)|By:, SA News Editor

Pluristem Therapeutics's (PSTI) shares are halted after it says that the FDA has suspended the Phase II trial of the company's placenta-based cell treatment for artery disease following "a serious allergic reaction" that caused the patient to be hospitalized. The patient has multiple diseases, "which may have influenced the severity of the event," and was discharged from hospital the following day. Shares are due to resume trading at 9:45. (PR)